Garry E Menzel Adaptimmune Therapeutics PLC (ADAP) insider trading activity

ADAP Quotes by TradingView

Garry E Menzel is Director of Adaptimmune Therapeutics PLC. Currently has a direct ownership of 75,056 shares of ADAP, which is worth approximately $54,790. The most recent transaction as insider was on Jul 10, 2023, when has been sold 47,702 shares (American Depositary Shares representing Ordinary Shares) at a price of $0.91 per share, resulting in proceeds of $43,408. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 75.1K
0% 3M change
0% 12M change
Total Value Held $54,790

Garry E Menzel Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 10 2023
SELL
Open market or private sale
$43,408 $0.91 p/Share
47,702 Reduced 38.86%
75,056 American Depositary Sh...
Jun 01 2023
BUY
Grant, award, or other acquisition
-
209,931 Added 50.0%
209,931 American Depositary Sh...

Also insider at

TCRR
TCR2 THERAPEUTICS INC. Healthcare
President and CEO
STOK
Stoke Therapeutics, Inc. Healthcare
BDTX
Black Diamond Therapeutics, Inc. Healthcare
GEM

Garry E Menzel

Director
Cambridge, MA

Track Institutional and Insider Activities on ADAP

Follow Adaptimmune Therapeutics PLC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ADAP shares.

Notify only if

Insider Trading

Get notified when an Adaptimmune Therapeutics PLC insider buys or sells ADAP shares.

Notify only if

News

Receive news related to Adaptimmune Therapeutics PLC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ADAP